Cargando…

Thromboembolic risks of recombinant factor VIIa use in warfarin-associated intracranial hemorrhage

Detalles Bibliográficos
Autores principales:	Chou, S, Cai, X, Konigsberg, R, Bresette, L, Henderson, G, Sorond, F, Ropper, A, Feske, S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068362/ http://dx.doi.org/10.1186/cc9853

Ejemplares similares

Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study
por: H-Y, Chou Sherry, et al.
Publicado: (2012)

Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
por: Yampolsky, Natalie, et al.
Publicado: (2014)

The use of recombinant factor VIIa as a haemostatic agent in ICU patients
por: Vernikos, P, et al.
Publicado: (2004)

Predicting response to recombinant activated factor VIIa administration in the critically ill
por: Pugh, R, et al.
Publicado: (2008)

Does recombinant factor VIIa change the inflammatory response to trauma? Preliminary results of inflammatory biomarkers in critically ill trauma patients
por: Lissauer, M, et al.
Publicado: (2006)

Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
por: Kissela, Brett M, et al.
Publicado: (2008)

Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants
por: Dang, Chi N, et al.
Publicado: (2010)

Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
por: Chapman, Scott A, et al.
Publicado: (2014)

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients
por: Park, Jeong A
Publicado: (2016)

Evaluation of Recombinant Factor VIIa Treatment for Massive Hemorrhage in Patients with Multiple Traumas
por: Koh, Young Rae, et al.
Publicado: (2012)

Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis
por: Yaghi, Shadi, et al.
Publicado: (2015)

Intracranial pressure after subarachnoid hemorrhage
por: Lombardo, A, et al.
Publicado: (2013)

Recombinant Factor VIIa in Post-partum Hemorrhage: A New Weapon in Obstetrician's Armamentarium
por: Magon, Navneet, et al.
Publicado: (2012)

Early use of factor VIIa in cardiac surgery is associated with lower rates of blood transfusions without impact on outcome
por: Galas, F, et al.
Publicado: (2010)

Warfarin overactivity
por: Yamanel, L, et al.
Publicado: (2005)

Preclinical trauma studies of recombinant factor VIIa
por: Schreiber, Martin A, et al.
Publicado: (2005)

Location and Characteristics of Warfarin Associated Intracranial Hemorrhage
por: Lee, Sang-Min, et al.
Publicado: (2014)

Simultaneous intracranial angiography and intraplaque hemorrhage imaging using SNAP
por: Wang, Jinnan, et al.
Publicado: (2013)

Clinical significance of prolonged QTc dispersion in spontaneous intracranial hemorrhage
por: Chun, BJ, et al.
Publicado: (2006)

Use of recombinant factor VIIa in orthotopic liver transplant
por: Bhatia, Pradeep
Publicado: (2011)

Fatal Intracranial Hemorrhage Associated with Oral Warfarin Use
por: Jimenez-Ruiz, Amado, et al.
Publicado: (2018)

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
por: Zollner, S, et al.
Publicado: (2014)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Life-Threatening Pulmonary Hemorrhage Responds to Recombinant Factor VIIa: A Case Series in South Florida Hospitals
por: Diaz, Raiko, et al.
Publicado: (2019)

Recombinant factor VIIa in severe trauma: further study needed
por: Galvan, Dan A, et al.
Publicado: (2006)

Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient
por: Martin, Jeremiah T., et al.
Publicado: (2009)

The utility of recombinant factor VIIa as a last resort in trauma
por: Mamtani, Rishi, et al.
Publicado: (2012)

Warfarin-associated fetal intracranial hemorrhage: a case report.
por: Lee, Ho-Chang, et al.
Publicado: (2003)

Delayed Intracranial Hemorrhage in Patients Taking Warfarin with Head Trauma
por: Macedo, Mark, et al.
Publicado: (2017)

Genetics of Warfarin Sensitivity in an Emergency Department Population with Thromboembolic
por: Johnson, Sara W., et al.
Publicado: (2011)

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009)

Violin concertos in C major, Hob. VIIa:1 ; in G major, Hob. VIIa:4 ; in A major, Hob. VIIa:3 /
por: Haydn, Joseph, 1732-1809
Publicado: (1989)

Dose effects of recombinant human IL-11 on the systemic hemodynamic function in hemorrhagic shock
por: Honma, K, et al.
Publicado: (2007)

Efficacy of recombinant activated factor VII in the management of severe hemorrhage following cardiac surgery
por: Trecova, N, et al.
Publicado: (2006)

Pro/Con Debate: Does recombinant factor VIIa have a role to play in the treatment of patients with acute nontraumatic hemorrhage?
por: Pieri, Paola, et al.
Publicado: (2006)

Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven(®))
por: Viuff, D., et al.
Publicado: (2008)

Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma
por: Mohr, Alicia M, et al.
Publicado: (2005)

Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
por: Puetz, John
Publicado: (2010)

Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism
por: Carney, Brian J., et al.
Publicado: (2020)

Brain injury biomarkers and inflammatory markerslike pronostic factors on mortality in patients with spontaneous intracranial hemorrhage (medical-adults intensive care)
por: Aguillón Prada, DL, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_faleucbhis5f27ijkl9nttglav